awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q49689930-1CC98A5E-0B13-4C0F-86EF-C8576B8FC369
Q49689930-1CC98A5E-0B13-4C0F-86EF-C8576B8FC369
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49689930-1CC98A5E-0B13-4C0F-86EF-C8576B8FC369
Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly.
P2860
Q49689930-1CC98A5E-0B13-4C0F-86EF-C8576B8FC369
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49689930-1CC98A5E-0B13-4C0F-86EF-C8576B8FC369
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
33374c2672669658c9567d9c67de6e9aadfd0759
P2860
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.